北京招聘

工作职责:

? Market and industry research on pharmaceutical and innovative oncology treatment development industries to summarize the development landscape and trend globally for strategical planning

? Monitor and help execute variety of corporate projects by providing insight and direction for key strategic levers such as market development, customer needs assessment, competitive advantage, market and/or product prioritization

? Prepare customer behavior analysis report and extract new insights by data dicing existing data, provide technical support to product manager for product designing and positioning

? Support fundraising, strategic financial planning and investment projects

?对制药和创新肿瘤治疗发展行业进行市场和行业研究，总结全球发展前景和趋势，以便进行战略规划

?通过为关键战略杠杆（如市场开发、客户需求评估、竞争优势、市场和/或产品优先级）提供洞察力和指导，监控和帮助执行各种公司项目

?准备客户行为分析报告，通过数据切割现有数据提取新见解，为产品经理提供产品设计和定位方面的技术支持

?支持筹资、战略财务规划和投资项目

任职资格:

? Ability to communicate tactical direction and related concepts clearly, orally and in writing, across internal and external audiences in both Chinese and English

? Strong analytical skills, ability to manage multiple tasks and work under pressure

? Self-motivation with a great ability to find solutions to complex problems.

? Team player with strong sense of responsibility

? BA, BS or equivalent required. Graduate degree is a plus

? A strategy consulting related working experience is strongly preferred

? 2-7 years total working experience in healthcare, insurance, financial advisory and business management experience, an oncology drug development working experience will be a plus

?能够用中英文在内部和外部环境中清晰、口头和书面地传达战术方向和相关概念

?较强的分析能力、管理多项任务的能力和在压力下工作的能力

?自我激励，能够找到解决复杂问题的方法。

?具有团队合作精神，责任心强

?需要BA、BS或同等学历。有研究生学历优先

?有战略咨询相关工作经验者优先

?2-7年医疗、保险、财务咨询和商业管理经验，有肿瘤药物开发工作经验者优先

领星隶属嘉信医疗服务集团（Carebridge Holdings），由中美生物医学科学家携手资深肿瘤专家共同开创的肿瘤精准医疗服务及科研平台，并与集团旗下的上海嘉会国际医院及《NEJM医学前沿》共同打造医学研三位一体的医疗生态系统。

领星旗下有两个子公司，领星医学通过临床全外显子组测序，多组学检测及定制化ctDNA监测等核心产品，将最新的基因测序技术应用到临床，为医生和患者提供肿瘤精准治疗方案筛选、实施和监测服务，致力于推动中国肿瘤个体化精准医疗的发展。

领星生物基于中国***规模的肿瘤临床全外显子组数据库, 通过整合多源异构医疗数据，利用人工智能等相关技术，前瞻性地整合肿瘤基因组数据和每位患者完整的临床路径，打造“基因+临床”精准医疗数据库，并结合其***的数据驱动算法，为制药行业合作伙伴提供Best-in-class的真实世界数据临床解决方案，积极推动肿瘤精准药物研发的发展。